Loading clinical trials...
Loading clinical trials...
Abciximab (ReoPro) in Acute Ischemic Stroke: A Phase III, Multinational, Multicenter, Randomized, Double-blind, Placebo-controlled Trial.
Conditions
Interventions
Abciximab
Start Date
October 1, 2003
Completion Date
December 1, 2005
Last Updated
May 17, 2011
NCT07237048
NCT06241677
NCT05651945
NCT07272239
NCT06954610
NCT07113067
Lead Sponsor
Centocor, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions